Median Diagnostics Inc

Median Diagnostics Inc exhibits a strong liquidity position, with a current ratio of 15.48, indicating a significant excess of current assets over current liabilities. The company's cash and equivalents amount to KRW 2,192,920,580, and its free cash flow stands at KRW 2,679,882,660, suggesting robust cash generation and minimal liquidity risk. The debt-to-equity ratio is 0.02, reflecting a conservative capital structure with minimal leverage. In terms of profitability, the company's return on equity (ROE) is 10.48%, and its return on assets (ROA) is 9.84%, both of which are strong indicators of efficient capital utilization and profitability. These metrics align with the industry's preferred focus on ROE and ROA as key performance indicators. The gross profit margin is 60.63% (KRW 7,254,466,930 gross profit on KRW 11,969,369,820 revenue), and the operating margin is 17.09% (KRW 2,044,466,920 operating income), both of which are favorable compared to industry medians. The company's revenue is primarily concentrated in its domestic market, with disclosed segments indicating a focus on veterinary medicine technology and product distribution. While the company does export, the input data does not provide specific geographic revenue breakdowns, and thus, the extent of international exposure remains unspecified. Looking ahead, the company's growth trajectory is supported by its strong cash flow generation and low debt levels. The capital expenditure of KRW -207,671,950 indicates a net outflow, but the magnitude is relatively small compared to the company's total assets of KRW 24,100,568,210. The outlook for the current fiscal year and the next fiscal year is not explicitly provided in the input data, but the company's financial health suggests a stable or growing revenue path. The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt-to-equity ratio and high cash reserves further support this assessment. There is no indication of dilution potential in the basic shares outstanding, as the diluted shares are equal to the basic shares. The company has not disclosed any recent events such as filings or transcripts that would suggest near-term risk factors. The company's recent financial performance and conservative capital structure suggest a stable and predictable business model. The absence of significant debt and the presence of strong cash reserves indicate that the company is well-positioned to weather economic downturns or industry-specific challenges.